CEACAM5 and neoplasm: The radiological tumour assessment at the end of chemotherapeutic treatment (November 2009) showed a volumetric progressive disease at the level of the pelvic cystic lesion (confirmed by cytological analysis), whereas a further reduction of CEA serum level (7 ng/ml) was observed.